NCT03104595View on ClinicalTrials.gov

Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

November 26, 2019

Study Completion Date

December 5, 2019

Conditions
Febrile Neutropenia
Interventions
DRUG

EC-18

oral administration

Trial Locations (3)

10408

National Cancer Center, Gyeonggi-do

03722

Yonsei University Health System Severance Hospital, Seoul

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Enzychem Lifesciences Corporation

INDUSTRY